Telethon Institute for Child Health Research, and Centre for Child Health Research, The University of Western Australia, Perth, Australia.
Curr Opin Allergy Clin Immunol. 2012 Apr;12(2):151-7. doi: 10.1097/ACI.0b013e3283520166.
Information is accumulating which implicates airway inflammation resulting from respiratory viral infections, acting against a background of atopy, in both the cause and pathogenesis of atopic asthma. This review brings together the most recent publications relevant to this rapidly evolving area, particularly those focusing on underlying pathogenic mechanisms.
Salient findings from the recent literature include increased respiratory infection-associated symptom severity/duration and loss of asthma control in atopic relative to nonatopic children; up-regulation of FcεR1 expression on circulating monocytes/dendritic cells occurs during virus-associated atopic asthma exacerbations, providing a mechanism for transient amplification of underlying allergic airways inflammation; high potency of hRV-type C in induction of infection-associated wheeze; Th2-polarized immunity to mucosal dwelling bacteria and protection against asthma; a role for IL-15 in viral-associated airways inflammation; vitamin D and protection against infection-associated asthma exacerbations; strategies for reduction of infection-associated wheezing severity by boosting mucosal Treg cell activity via immunostimulation of the gut mucosa.
Research in this area is pointing towards new rationales for development of early intervention strategies for prevention of asthma initiation and progression in childhood, based on control of respiratory infections and/or sensitization to aeroallergens.
越来越多的信息表明,呼吸道病毒感染引起的气道炎症,加上特应性背景,在特应性哮喘的病因和发病机制中都起作用。这篇综述汇集了与这一快速发展领域相关的最新出版物,特别是那些侧重于潜在发病机制的出版物。
最近文献中的突出发现包括,与非特应性儿童相比,特应性儿童呼吸道感染相关症状的严重程度/持续时间增加,哮喘控制丧失;病毒相关特应性哮喘恶化期间,循环单核细胞/树突状细胞上 FcεR1 表达上调,为潜在过敏性气道炎症的短暂放大提供了机制;高致病性 hRV 型 C 诱导感染相关喘息的能力;黏膜定植细菌的 Th2 极化免疫和对哮喘的保护;IL-15 在病毒相关气道炎症中的作用;维生素 D 可预防感染相关哮喘恶化;通过刺激肠道黏膜增强黏膜 Treg 细胞活性来降低感染相关喘息严重程度的策略。
该领域的研究为预防儿童哮喘的发生和发展提供了新的理由,基于控制呼吸道感染和/或对过敏原的致敏,制定早期干预策略。